AMED selects NEC for design of universal vaccine against influenza virus strains
NEC was selected following its submission of a research project titled “Development of universal vaccine design technology using…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Akums launches tamsulosin + tadalafil capsule to treat enlarged prostate and erectile dysfunction…
Each hard gelatin capsule is composed of Tamsulosin Hydrochloride IP at 0.4/0.4mg (in its extended-release form) and Tadalafil IP…
Sun Pharma and Pharmazz sign licensing pact to launch Tyvalzi (Sovateltide) in India
Sovateltide is indicated for treating cerebral ischemic stroke
Zydus gets EIR for injectables manufacturing facility at Zydus Biotech Park
The inspection had concluded with NIL observations
HepaStem seems most promising pipeline agent for decompensated cirrhosis due to NASH: GlobalData
HepaStem is a stem cell therapy consisting of liver-derived mesenchymal stem cells (MSC) that addresses different components of…
Pee Safe partially closes Series B round with $3 mn from Natco Pharma, Rainmatter Health
The newly acquired funds will be utilised to expand retail presence in India, expand overseas with an omni-channel approach and…
Redx will become a key upcoming player in IPF treatment with FDA’s ODD for zelasudil: GlobalData
KOLs interviewed by GlobalData noted that there is a huge unmet need in the IPF space, which is pushing companies to look for…
BMS mezigdomide, iberdomide to transform multiple myeloma treatment landscape: GlobalData
The sales for mezigdomide and iberdomide are predicted to reach $125 million and $389 million, respectively
Crohn’s disease treatment market sees major shift with biosimilars and next-gen therapies:…
The recent launch of adalimumab biosimilars not only will cause an overall reduction in the cost of treatment, but also provide…
Lupin partners with Cost Plus Drugs, COPD Foundation
The collaboration seeks to expand availability of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, to COPD patients in the US…
There has been a strong wave of M&A activity in Indian domestic formulations space
Analysing the increased M&A and investment activity across India’s API, formulations and nutraceutical ingredients, driven by…
Is India capable of ensuring equitable access to biopharmaceuticals?
By introducing cost-effective drugs for critical illness by leveraging path-breaking manufacturing technologies, India could…
Biocon Biologics completes integration of Viatris Biosimilars’ Business in North America
With the completion of the North America integration, the existing commercialised portfolio of biosimilars, Ogiviri…
IndiaRF to acquire API and CRAMS business of Ind-Swift for Rs 1,650 cr
Ind-Swift reported a consolidated revenue of Rs 1,207 crores and consolidated EBITDA of Rs 256 crores in FY23
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
DCGI issues advisory about Digene Gel following Abbott’s voluntary recall
The advisory instructs healthcare professionals to promptly report any suspicious cases of adverse events linked to this product
Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
The latest data from the final analysis of the Phase II OCEAN(a)-DOSE study showed that olpasiran reduced Lp(a) levels in patients…
Viatris gets tentative nod from US FDA for Abacavir/Dolutegravir/Lamivudine to treat paediatric HIV…
Tentative approval will help enhance access to WHO-recommended paediatric regimen with the goal of improved adherence of HIV…
Cybersecurity job postings in pharma industry up at 34 per cent CAGR since 2020: GlobalData
Growing digital engagement, coupled with the rising occurrence of data breaches, has prompted pharma companies to place a…
Enzene Biosciences inaugurates R&D Center with open lab setup in Pune
The new R&D centre signals strategic growth plans, expanded capabilities and enhanced services